Company: RGNT
Filing Date: 2025-02-12
Form Type: DRS/A
Source: 0001213900-25-012299
Chunk: 98

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-02-12
Form: DRS/A
Chunk 98
---
 historical net tangible book value of $ (38.69) million, or $(596.47) per
Ordinary Share. Our net tangible book value per share represents total tangible assets less total liabilities, divided by which was the
number of Ordinary Shares outstanding on June 30, 2024.

Our pro forma net tangible book value as of June 30, 2024 was $(1,062) million, or $(0.68) per Ordinary Share. Pro forma net tangible book value per share represents total tangible assets less total liabilities, divided by which is the number of Ordinary Shares outstanding as of June 30, 2024, after giving effect to the following events as if each event had occurred on June 30, 2024: (i) the issuance of 1,006,106 Ordinary Shares upon the automatic conversion of the 1,006,106 Preferred Shares issued and outstanding as of the date hereof, which will automatically convert upon the completion of this offering at a 1:1 ratio; (ii) the issuance of 243,955 Ordinary Shares upon the automatic conversion of the $900,000 outstanding principal of 2020 CLAs, which will occur upon the completion of this offering; and (iii) the issuance of 221,456 Ordinary Shares upon the automatic conversion of the $450,000 outstanding principal of 2024 CLAs, which will occur upon the completion of this offering.

After giving effect to the additional issuance of the sale of Ordinary Shares in this offering at an assumed initial public offering price of $ per Ordinary Share, which is the midpoint of the price range set forth on the cover page of this prospectus, after deducting the estimated underwriting discounts and commissions and estimated offering expenses, but assuming no exercise of the Representative’s Warrant, and giving effect to the repayment of the Bridge Loan in the total amount of $ ,
our pro forma as adjusted net tangible book value at June 30, 2024 would have been $ per Ordinary Share. This represents an immediate increase in pro forma as adjusted net tangible book value of $ per share to existing shareholders and immediate dilution of $ per Ordinary Share to new investors. The following table illustrates this dilution per Ordinary Share:

| Assumed public offering price per Ordinary Share                                                        |     | $ |         |   |
| Historical net tangible book value per share as of ‌ June ‌30, 2024                                     |     |   | (596.47 | ) |
| Increase in net tangible book value